Overview of docetaxel (taxotere) in the treatment of non-small cell lung cancerFOSSELLA, F. V.Seminars in oncology. 1999, Vol 26, Num 3, pp 4-8, issn 0093-7754, SUP11Article

The use of docetaxel (taxotere) in patients with advanced non-small cell lung cancer previously treated with platinum-containing chemotherapy regimensFOSSELLA, F. V; RIGAS, J.Seminars in oncology. 1999, Vol 26, Num 3, pp 9-12, issn 0093-7754, SUP11Article

Docetaxel in the treatment of non-small cell lung cancer : Review of single-agent trialsFOSSELLA, F. V.Seminars in oncology. 1999, Vol 26, Num 5, pp 17-23, issn 0093-7754, SUP16Conference Paper

Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinomaGLISSON, B; LEE, J. S; PALMER, J et al.Cancer. 1998, Vol 82, Num 2, pp 301-308, issn 0008-543XArticle

A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancerROTH, J. A; FOSSELLA, F; ATKINSON, E. N et al.Journal of the National Cancer Institute. 1994, Vol 86, Num 9, pp 673-680, issn 0027-8874Article

Optimisation of bronchial brachytherapy catheter placement with a modified airway stentKENNEDY, M. P; JIMENEZ, C. A; CHANG, J et al.The European respiratory journal. 2008, Vol 31, Num 4, pp 902-903, issn 0903-1936, 2 p.Article

Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancerNEMUNAITIS, J; SWISHER, S. G; FOSSELLA, F et al.Journal of clinical oncology. 2000, Vol 18, Num 3, pp 609-622, issn 0732-183XArticle

The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancerWEISS, G. J; ROSELL, R; KELLY, K et al.Annals of oncology. 2007, Vol 18, Num 3, pp 453-460, issn 0923-7534, 8 p.Article

Postoperative radiotherapy increases locoregional control of patients with stage IIIA non-small-cell lung cancer treated with induction chemotherapy followed by surgeryTAYLOR, N. A; LIAO, Z. X; STEVENS, C et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 3, pp 616-625, issn 0360-3016, 10 p.Conference Paper

Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung CancerSWISHER, S. G; ROTH, J. A; HONG, W. K et al.Journal of the National Cancer Institute. 1999, Vol 91, Num 9, pp 763-771, issn 0027-8874Article

Phase I study of paclitaxel administered by ten-day continuous infusionSHADE, R. J; PISTERS, K. M. W; HUBER, M. H et al.Investigational new drugs. 1998, Vol 16, Num 3, pp 237-243, issn 0167-6997Article

Systemic treatment of non-small-cell lung cancerLENZI, R; FOSSELLA, F. V; LEE, J. S et al.Comprehensive therapy. 1992, Vol 18, Num 3, pp 27-30, issn 0098-8243Article

A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancerMASSARELLI, E; ANDRE, F; LIU, D. D et al.Lung cancer. 2003, Vol 39, Num 1, pp 55-61, issn 0169-5002, 7 p.Article

Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIa non-small-cell lung cancerROTH, J. A; ATKINSON, E. N; HONG, W. K et al.Lung cancer. 1998, Vol 21, Num 1, pp 1-6, issn 0169-5002Article

Integration of filgrastim into chemoradiation for limited small cell lung cancer : A phase I studyGLISSON, B; KOMAKI, R; JIN SOO LEE et al.International journal of radiation oncology, biology, physics. 1998, Vol 40, Num 2, pp 331-336, issn 0360-3016Article

Phase II study of sulofenur (LY 186641) : a Novel Antineoplastic Agent in Advanced Non-Small Cell Lung CancerMUNSHI, N. C; SEITZ, D. E; FOSSELLA, F et al.Investigational new drugs. 1993, Vol 11, Num 1, pp 87-90, issn 0167-6997Article

Emerging therapies in non-small-cell lung cancerKHURI, F. R; HERBST, R. S; FOSSELLA, F. V et al.Annals of oncology. 2001, Vol 12, Num 6, pp 739-744, issn 0923-7534Article

Summary of phase II data of docetaxel (Taxotere), an active agent in the first- and second-line treatment of advanced non-small cell lung cancerFOSSELLA, F. V; JIN SOO LEE; BERILLE, J et al.Seminars in oncology. 1995, Vol 22, Num 2, pp 22-29, issn 0093-7754, SUP4Article

Management strategies for recurrent non-small cell lung cancerFOSSELLA, F. V; JIN SOO LEE; WAUN KI HONG et al.Seminars in oncology. 1997, Vol 24, Num 4, pp 455-462, issn 0093-7754Article

Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastasesBAYOUTH, J. E; MACEY, D. J; KASI, L. P et al.JNM. The journal of nuclear medicine (1990). 1994, Vol 35, Num 1, pp 63-69Article

A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non-small-cell lung cancer : A 5-year follow-up reportLEE, J. S; KOMAKI, R; FOSSELLA, F. V et al.International journal of radiation oncology, biology, physics. 1998, Vol 42, Num 3, pp 479-486, issn 0360-3016Article

Phase II study of intravenous adenosine 5'-triphosphate in patients with previously untreated stage IIIB and Stage IV non-small cell lung cancerHASKELL, C. M; MENDOZA, E; PISTERS, K. M. W et al.Investigational new drugs. 1998, Vol 16, Num 1, pp 81-85, issn 0167-6997Article

Analysis of urine samples from metastatic bone cancer patients administered ¹⁵³Sm-EDTMPGOECKELER, W. F; STONEBURNER, L. K; KASI, L. P et al.Nuclear medicine and biology. 1993, Vol 20, Num 5, pp 657-661, issn 0969-8051Article

A phase I investigation of the sequential use of methotrexate and paclitaxel with and without G-CSF for the treatment of solid tumorsHUBER, M. H; LEE, J. S; NEWMAN, R. A et al.Annals of oncology. 1996, Vol 7, Num 1, pp 59-63, issn 0923-7534Article

Phase II study of combination therapy with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small-cell lung cancerSHIN, D. M; DHINGRA, H. M; LEE, J. S et al.American journal of clinical oncology. 1992, Vol 15, Num 3, pp 194-199, issn 0277-3732Article